inVentiv closes i3 deal
13 June 2011 | Jonathan Hare Scrip Clinical Research
FINANCE ROUNDUP: Will VC Be Last Man Standing If Biotech Bubble Bursts? Sirona Forfeits Premium For Significant Benefits Dentsply Merger Will Bring Wuxi Pushing Ahead with $3bn Go-Private Deal Interview: Dr Reddy's CEO on move from curing diseases to managing health
Other Features & Analysis
Breaking through the sales plateau in 3 stages Expert view: Navigating the changing landscape of transfer pricing Conducting drug clinical trials in Russia: today and what lies ahead With $36bn from Teva, what should Allergan buy next?